Live
Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal CancerClinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion UncoveredClinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni SyndromeClinical OMICsCAR T Success Hinges on Microenvironment Response in GBMEndpoints NewsFDA warns telehealth companies over compounded GLP-1sBioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDAEndpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy saysEndpoints NewsHackers claim they stole Novo Nordisk AI models, manufacturing recipesEndpoints NewsIn second reversal, FDA gives uniQure a green light to seek accelerated approvalBioPharma DiveJazz zeroes in on next-gen T cell engagers with AbCellera dealClinical OMICsVibrating Pill Predicts Anorexia RelapseBioWorldFlexibility restored? Uniqure plans for BLA filing in Huntington’s
Agilent Mar 18, 2026

Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch

Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch

Original
Body unavailable. Use the original source.